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Congenital heart diseases (CHDs) are one of the widespread congenital problems of neonates and are an important cause of morbidity and mortality in the infancy period. 
A lot of children born with CHD in developing countries cannot 
be recognized early to avoid irreversible pulmonary vascular 
disease [1,2]. Very often, it happens that newborn babies, who are 
discharged as normal, are diagnosed later on with CHD, which 
makes it important to detect them before getting discharged from 
hospital. Hence, all CHDs should be regarded as main targets of 
neonatal screening in developing countries, especially like ours 
and it becomes important to detect those babies who are normal 
at birth, but with CHD to prevent the mortality and morbidity. 
As such, some have proposed that pulse oximetry be considered 
as a vital sign equivalent in importance to pulse, respiration, and 
blood pressure [3]. For this, if we use pulse oximetry screening 
soon after delivery, we can detect some of the CHDs.
In the past few years, many studies have been done for the 
screening of CHD in the neonatal period and few of them have 
utilized pulse oximetry for the screening of CHD along with 
routine clinical assessment [4-9]. However, most of these studies 
have been done in developed countries and very few studies 
have been done in developing countries [10,11], among which 
only a few Indian studies [3,12] are available which detected 
CHDs using pulse oximetry saturation. A study from the United 
States showed that 25% of the infants with critical CHD were not 
diagnosed until after discharge from the newborn nursery [13].
Critical CHD, which by definition required surgery or catheter 
intervention in the 1st year of life and duct dependent critical 
CHD includes coarctation of the aorta, interrupted aortic arch, 
hypoplastic left heart syndrome, pulmonary atresia, and tetralogy 
of Fallot with severe pulmonary stenosis [10]. These CHDs may 
manifest with sudden and profound worsening clinical status in 
the 1st day and week of life corresponding to changes in pulmonary 
vascular resistance and closure of the ductus. Critical CHD in the 
newborn may have borderline low oxygen saturation (SpO2) with 
unrecognized cyanosis clinically.
ABSTRACT
Introduction: Many studies have been done for screening of congenital heart disease (CHD) in the neonatal period utilizing pulse 
oximetry as a screening tool along with routine clinical assessment, but none of them from our province. Objective: The objective 
of the study was to find out the diagnostic accuracy of pulse oximeter at three different sites as a screening tool to diagnose CHD 
among neonates. Methods: A diagnostic study was conducted in neonatal intensive care unit of a tertiary care hospital of Odisha 
from October 2016 to September 2018 after approval from the Institutional Ethics Committee. Three hundred and seventy-four 
neonates (both inborn and outborn) with gestational age >34 weeks were included in the study. Oxygen saturation (SpO2) in the 
right hand (RH), right foot (RF), and left foot (LF) was estimated by pulse oximeter among all participants after 10 min of postnatal 
life. All the study subjects were evaluated by two-dimensional (2D) echocardiography for the detection of CHDs. All the diagnostic 
accuracy tests (sensitivity [Sn], specificity [Sp], positive predictive value, negative predictive value, and diagnostic odds ratio) were 
calculated taking 2D echocardiography as the gold standard with software, and for all statistical purpose, p<0.05 was considered 
statistically significant. Results: Cutoff value of the RH SpO2 was 90.0% with Sn of 68.80% and Sp of 98.20%; area under curve 
(AUC) 0.851 (0.766 and 0.914), p<0.001, for the RF, SpO2 was 90.0% with Sn 78.0% and Sp 92.1%; AUC 0.865 (0.782 and 0.925), 
p<0.001, and for LF, it was 87% with Sn 77.1% and Sp 94.0%; AUC 0.864 (0.781 and 0.924), p<0.001. Conclusion: Along with 
the clinical skills, pulse oximetry can be used as an early screening tool for the detection of CHD in the neonatal period and of three 
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Pulse oximetry has the potential to identify hypoxemia that 
might not otherwise produce visible cyanosis. Pulse oximetry is 
highly specific for the detection of critical CHDs with moderate 
sensitivity (Sn) that meets criteria for universal screening [9]. 
Pulse oximetry monitoring is also capable of detecting other 
conditions that include hypoxia including some lung conditions 
and persistent pulmonary hypertension of the newborn (PPHN). 
The investigators observed that pulse oximetry is much more 
effective in identifying infants with critical CHD and is more 
accurate and much less expensive than screening all newborns 
with echocardiography. Hence, our objective was to find out the 
diagnostic accuracy of pulse oximeter at three different sites as a 
screening tool for CHDs among neonates.
METHODS
The present Phase-II diagnostic study was conducted in NICU of 
a tertiary care hospital situated in the western part of Odisha, from 
October 2016 to September 2018 after getting approval from the 
Institutional Ethics Committee. Minimum sample size calculated 
was 374 using n Master v2.0 taking the Sn of pulse oximetry 
as 58.33% [14] and with an absolute precision of 5% and 95% 
confidence interval after satisfying predefined inclusion and 
exclusion criteria. Inclusion criteria were both inborn and outborn 
neonates with gestational age >34 weeks, whereas exclusion 
criteria were neonates with respiratory illnesses, congenital lung 
abnormalities, or malformations.
All consecutive newborns admitted to NICU satisfying the 
predefined inclusion criteria were enrolled in the study after taking 
written informed consent from parents and/or legal heir and were 
assessed for SpO2 monitoring with pulse oximetry after 10 min of 
birth in case of inborn and at time of admission for outborn (Fig.1). 
Two-dimensional (2D) Doppler echocardiography (Phillips HD 11 
XE, New York, USA) was done in each baby for the detection of CHD 
in the department of cardiology and was taken as the gold standard 
for estimating the accuracy of pulse oximetry. Data were collected 
regarding the pre-ductal (right hand [RH]) and post-ductal (right foot 
[RF] and left foot [LF]) SpO2. Pre-ductal site conventionally RH was 
taken due to non-significant difference in SpO2 level between RH 
and LH as per previous research article by Ruegger et al. [15].
Difference between pre-ductal and post-ductal SpO2 (%) 
was calculated for each case. The cutoff values were calculated 
by applying receiver operating characteristic (ROC) curve with 
relevant statistics such as Sn, specificity (Sp), area under curve 
(AUC), positive predictive value (PPV), negative predictive value 
(NPV), positive likelihood ratio (LR+), negative likelihood ratio 
All Outborn and inborn neonates of gestational age 
> 34 weeks were enrolled for the study (n = 374)
SpO2 was measured at 3 different sites (RH, RF, LF) and 
also difference in SpO2 between RH – RF & RH – LF were 
estimated
Considering 2D echocardiography as gold standard and applying Receiver Operating 
Characteristic curve (ROC), cut off values of SpO2 at 3 different sites (RH, RF, LF) 
were estimated along with cut off values of difference in SpO2 between RH-RF and 
RH-LF
Based upon the cut off values of SpO2 at 3 different sites (RH, RF, LF) and cut off values 
of difference in SpO2 between RH-RF and RH-LF, diagnostic accuracy test of pulse 
oximetry at each site was measured in terms of Sn, Sp, PPV, NPV and DOR
On basis of different diagnostic accuracy tests of pulse oximetry at 3 
different sites, right foot (RF) seems to be better option for taking reading of 
SpO2 for early detection of CHD 
Figure 1: Study flow chart
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(LR−) of RH, RF, and LF, and difference between RH and RF 
and between RH and LF using the SPSS v25 (IBM, New York) 
and Dxt v1.0 (BRTC, Bagayam, Vellore). Based on these, we 
have calculated the Sn, Sp, PPV, NPV, LR+, LR− and diagnostic 
odds ratio (DOR) of RH, RF, and LF, and difference between RH 
and RF, and RH and LF. For all statistical purpose, p<0.05 was 
considered statistically significant.
RESULTS
Among 374 neonates included in our study, the male-to-female 
ratio was 1.04:1. The mean gestational age was 37.51±1.69 weeks, 
whereas mean postnatal age was 11.85±5.78 h. The mean SpO2 of 
the RH was 90.38±12.64%, whereas mean SpO2 of the RF and 
LF was 88.98±14.13% and 88.39±14.82%, respectively. The 
mean difference of SpO2 between RH and RF was 1.87±1.89% 
and between RH and LF was 2.48±2.63%. Of 374 neonates 
screened with 2D echocardiography, 109 (29.14%) neonates were 
detected with CHDs. Of 109 neonates with CHD, 103 neonates 
were having acyanotic CHD (59 patent ductus arteriosus, 37 
ventricular septal defects, and seven arterial septal defects) and 
rest six had cyanotic CHD (four PPHN, one transposition of great 
arteries, and one tricuspid atresia). All six cyanotic CHDs were 
having poor saturation.
Cutoff value of the RH SpO2 was 90.0% with Sn 68.80% and 
Sp 98.20%; AUC 0.851 (0.766 and 0.914), p<0.001, LR+=10.13, 
and LR−=0.335 (Fig. 2). Cutoff value of the RF SpO2 was 90.0% 
with Sn 78.0% and Sp 92.1%; AUC 0.865 (0.782 and 0.925), 
p<0.001, LR+=9.845, and LR−=0.239 (Fig. 2). Cutoff value 
of the LF SpO2 was 87% with Sn 77.1% and Sp 94.0%; AUC 
0.864 (0.781 and 0.924), p<0.001, LR+=12.764, and LR−=0.244 
(Fig. 1).
Cutoff value of difference in SpO2 between RH and RF was 2 
with Sn 75.23% and Sp 79.63%; AUC 0.805 (0.713 and 0.877), 
p<0.001, LR+=3.692, and LR−=0.311 (Fig. 3). Cutoff value of 
difference in SpO2 between RH and LF was 3 with Sn 77.06% and 
Sp 85.52%; AUC 0.842 (0.755 and 0.907), p<0.001, LR+=4.981, 
and LR−=0.271 (Fig. 3).
Based on the above parameters, we have calculated the Sn, 
Sp, PPV, NPV, LR+, LR−, and DOR of RH, RF, and LF and 
are shown in Table 1. Sn of difference between RH and LF was 
highest among all (83.2%), but DOR was highest for LF (52.083). 
LR+ was highest for RF (11.494). Applying clinical knowledge 
along with the statistical parameters, it is assumed that it is better 
to take RF for screening of CHDs in newborns.
DISCUSSION
Neonates with CHD can be diagnosed on the basis of physical 
findings. However, these findings are not always evident before 
hospital discharge or within the first 48 h of life. Newborns 
with CHD, especially critical CHD, are susceptible to a sudden 
worsening in clinical status without an accurate diagnosis [13]. 
Early diagnosis of CHD can significantly impact the outcome; 
hence, it becomes vital to identify, evaluate, and design strategies 
to improve early detection. In developing countries like 
India [3,12], this method can be very helpful in the early detection 
Figure 2: Receiver operating characteristic curve of the right hand, 
right foot, and left foot
Figure 3: Receiver operating characteristic curve of the right hand-
right foot and RH-left foot
Table 1: Diagnostic accuracy parameters of RH, RF, LF, RH-RF, and RH-LF
Different Sites Sn@ Sp# PPV$ NPV$$ LR+* LR−** DOR*** YI**** Sn@
LF 80.6 92.6 80.6 92.6 10.919 0.21 52.083 0.732 80.6
RF 77.8 93.2 82.4 91.2 11.494 0.238 48.222 0.71 77.8
RH 69.2 93.7 80.9 88.8 10.995 0.328 33.485 0.629 69.2
RH-LF 83.2 71.9 54.3 91.4 2.961 0.234 12.658 0.551 83.2
RH-RF 75.5 78.7 58.4 89.0 3.548 0.312 11.39 0.542 75.5
@Sensitivity (%), #Specificity (%), $Positive predictive value (%), $$Negative predictive value (%), *Positive likelihood ratio, **Negative likelihood ratio, ***Diagnostic odds ratio, 
****Youden index, RH: Right hand, RF: Right foot, LF: Left foot
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of CHD as fetal echocardiography is not routinely done. A study 
by Levesque et al., in 2000, described the normal range of SpO2 
in term newborns in the 1st day of life [16]. These investigators 
evaluated normal oximetry values at sea level, from admission to 
the newborn nursery to discharge.
In the scientific statement from the American Heart Association 
and the American Academy of Paediatrics, Mahle et al. evaluated 
the statistical analysis of pulse oximetry screening with data from 
10 different studies [17]. Analysis of the studies with infants who 
were evaluated after 24 h of age showed 18 false positives, along 
with 7 false negatives and 51,063 true negatives. From these data, 
the Sn of pulse oximetry was 69.9% and Sp was 99.9%, with 
an NPV of 99.9% and a PPV of 47% [17] which is more or less 
similar to our present study.
However, the DOR was highest for LF in our study, which 
means, of three different sites for measuring SpO2 among 
neonates, the RF is the better option. The Sn of pulse oximetry 
of our study coincides with the previous studies [11,18-20] but 
higher than the study done in Thailand in January 2019 [10]. The 
reason may be due to the fact that they have taken only critical 
CHDs, but the present study was aimed for the screening purpose, 
i.e., we have taken all neonates with and without CHD.
Although there were different studies regarding pulse 
oximetry as a screening tool for CHD in neonates [21-23], the 
present study is quite different because all previous studies were 
taken a proposed algorithm for screening and no study evaluated 
parameters such as individual limb oximetry and attempted to 
find out a cutoff in terms of the difference between oximetry in 
different limbs.
Like other studies, the current study is also not devoid of 
limitations. Since this is a Phase II diagnostic study, the level 
of evidence is low. As it is a hospital-based study in a tertiary 
care center, its result could not be generalized. Since the non-
probability sampling technique was used, errors and biases could 
not be avoided. Hence, in a future, Phase III diagnostic study is 
required to boost upon the existing knowledge.
CONCLUSION
Early diagnosis of CHD is important for appropriate management 
of potentially critical (yet often treatable) conditions. 
Echocardiography is the best, but is expensive, and requires 
considerable expertise, and is not easily available at most centers. 
Along with the clinical skills, pulse oximetry can be used as an 
early screening tool for the detection of CHD in the neonatal 
period and of three different sites, the RF seems to be a better 
option for early recognition.
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